0001179110-21-008584.txt : 20210903
0001179110-21-008584.hdr.sgml : 20210903
20210903160607
ACCESSION NUMBER: 0001179110-21-008584
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210902
FILED AS OF DATE: 20210903
DATE AS OF CHANGE: 20210903
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Boulding Mark Elliott
CENTRAL INDEX KEY: 0001578852
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35969
FILM NUMBER: 211236502
MAIL ADDRESS:
STREET 1: C/O PTC THERAPEUTICS, INC.
STREET 2: 100 CORPORATE COURT
CITY: SOUTH PLAINFIELD
STATE: NJ
ZIP: 07080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: PTC THERAPEUTICS, INC.
CENTRAL INDEX KEY: 0001070081
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043416587
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 100 CORPORATE COURT
CITY: SOUTH PLAINFIELD
STATE: NJ
ZIP: 07080-2449
BUSINESS PHONE: 9082227000
MAIL ADDRESS:
STREET 1: 100 CORPORATE COURT
CITY: SOUTH PLAINFIELD
STATE: NJ
ZIP: 07080-2449
FORMER COMPANY:
FORMER CONFORMED NAME: PTC THERAPEUTICS INC
DATE OF NAME CHANGE: 19980909
4
1
edgar.xml
FORM 4 -
X0306
4
2021-09-02
0
0001070081
PTC THERAPEUTICS, INC.
PTCT
0001578852
Boulding Mark Elliott
C/O PTC THERAPEUTICS, INC.
100 CORPORATE COURT
SOUTH PLAINFIELD
NJ
07080
0
1
0
0
Exec. VP and CLO
Common Stock
2021-09-02
4
M
0
3363
18.01
A
51737
D
Common Stock
2021-09-02
4
S
0
3363
45.012
D
48374
D
Stock Option (Right to Buy)
18.01
2021-09-02
4
M
0
3363
18.01
D
2028-01-02
Common Stock
3363
15653
D
Stock Option (Right To Buy)
218.4
2022-01-10
Common Stock
191.0
191
D
Stock Option (Right To Buy)
51.0
2025-01-01
Common Stock
85600.0
85600
D
Stock Option (Right To Buy)
30.86
2026-01-03
Common Stock
70000.0
70000
D
Stock Option (Right to Buy)
11.23
2027-01-02
Common Stock
4563
4563
D
Stock Option (Right To Buy)
33.02
2029-01-21
Common Stock
72500.0
72500
D
Stock Option (Right To Buy)
33.02
2029-01-21
Common Stock
17500.0
17500
D
Stock Option (Right To Buy)
51.16
2030-01-28
Common Stock
59500.0
59500
D
Stock Option (Right to Buy)
66.49
2031-01-05
Common Stock
59500
59500
D
This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on March 10, 2021.
This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $45.00 to $45.04 per share. The reporting person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
This option was granted on January 3, 2018, and vests over four years, with 25% of the shares underlying the option vesting on January 3, 2019, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 3, 2019.
Currently exercisable.
This option was granted on January 22, 2019 and vests over four years, with 25% of the shares underlying the option vesting on January 22, 2020, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning April 22, 2020.
This option was granted on January 22, 2019 and vests over four years, with 50% of the shares underlying the option vesting on January 22, 2022, and the remaining 50% of the original number of shares underlying the option vesting on January 22, 2023.
This option was granted on January 29, 2020, and vests over four years, with 25% of the shares underlying the option vesting on January 29, 2021, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 29, 2021.
This option was granted on January 6, 2021, and vests over four years, with 25% of the shares underlying the option vesting on January 6, 2022, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 6, 2022.
/s/ Avraham S. Adler, attorney-in-fact
2021-09-03